NPUK is governed by its Articles and Memorandum and run by a Board of Trustees.
Our Annual Reports review our performance each year and the progress we’re making against our aims and objectives.
Our Report and Financial Statements provide a financial review each year.
11.05.21
GAINESVILLE, FL–(Businesswire)–May 11, 2021–Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families suffering from diseases, announced today it has appointed Lori McKenna Gorski as Global Head of Patient Advocacy...
Read more06.05.21
Today Action for Rare Disease Empowerment (ARDEnt) has published its findings andrecommendations in the report ‘Making The Unseen Seen: Rare disease and lessons learned from the COVID-19 pandemic’...
Read more
